Three Dosing Schedules of Oral Rigosertib in MDS Patients

Clinical trial NCT02075034 · WITHDRAWN

Trial details

NCT number: NCT02075034
Sponsor: Traws Pharma, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2014-05-01
Primary completion: 2019-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.